Insider · CIK 0001847763
Kevin Munoz
Files at SILO (Silo Pharma, Inc.). First filing -, latest -.
In brief
Kevin Munoz files SEC Form 4 as director at SILO (Silo Pharma, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Kevin Munoz has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 23, 2025 | SILO Silo Pharma, Inc. | AGrant or award Options (right to buy)derivative | +50,000 | $0.00 | $0 | 53,425 | May 27, 2025 |
Questions about Kevin Munoz
Answered from the filings on this page, as of the latest one.
Is Kevin Munoz buying or selling?
Kevin Munoz has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Kevin Munoz's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Kevin Munoz has 0.
Where does Kevin Munoz file Form 4?
Kevin Munoz has filed Form 4 at SILO (Silo Pharma, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.